Hardman Johnston Global Advisors’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
OAG
Hardman Johnston Global Advisors's ABBV Position: Q1 2019 in Review
Hardman Johnston Global Advisors sold out of AbbVie (ABBV) in Q1 2019, closing a stake of 47,758 shares — an estimated $4.4M sold.
Hardman Johnston Global Advisors first reported a position in ABBV in Q2 2013 and held it in 23 quarters. The position peaked at $4.8M in Q4 2017. 2,034 funds tracked by Wall St. Rank hold ABBV as of Q1 2019.
- Hardman Johnston Global Advisors reported no remaining AbbVie position as of Q1 2019 after selling out during the quarter.
- Hardman Johnston Global Advisors sold 47,758 AbbVie shares in Q1 2019, an estimated $4.4M.
- Hardman Johnston Global Advisors first reported a position in AbbVie in Q2 2013 and held it in 23 quarters.
- Hardman Johnston Global Advisors's AbbVie position peaked at $4.8M in Q4 2017.
- 2,034 funds tracked by Wall St. Rank held AbbVie as of Q1 2019.
Based on Hardman Johnston Global Advisors's 13F filing for Q1 2019, filed 3 May 2019.